Is It Time To Reassess Privia Health Group (PRVA) After Prolonged Share Price Weakness?

Simply Wall St.03-25 09:11

For investors considering whether Privia Health Group at around US$21.03 is attractively priced or potentially a value trap, this article walks through key clues in the current market pricing. The ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622045311?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063","is_english":true,"pubTime":"2026-03-25 09:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622045311","market":"us","top_or_hot":-1,"title":"Is It Time To Reassess Privia Health Group (PRVA) After Prolonged Share Price Weakness?","media":"Simply Wall St.","content":"<div>\n<p>For investors considering whether Privia Health Group at around US$21.03 is attractively priced or potentially a value trap, this article walks through key clues in the current market pricing. The ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/is-it-time-to-reassess-privia-health-group-prva-after-prolon\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess Privia Health Group (PRVA) After Prolonged Share Price Weakness?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess Privia Health Group (PRVA) After Prolonged Share Price Weakness?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-25 09:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/is-it-time-to-reassess-privia-health-group-prva-after-prolon><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For investors considering whether Privia Health Group at around US$21.03 is attractively priced or potentially a value trap, this article walks through key clues in the current market pricing. The ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/is-it-time-to-reassess-privia-health-group-prva-after-prolon\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/is-it-time-to-reassess-privia-health-group-prva-after-prolon","article_id":"2622045311","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prva/privia-health-group/news/is-it-time-to-reassess-privia-health-group-prva-after-prolon","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622045311","pubTimestamp":1774401081,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"For investors considering whether Privia Health Group at around US$21.03 is attractively priced or potentially a value trap, this article walks through key clues in the current market pricing.\nThe stock has seen mixed sentiment, with returns of a 4.8% decline over 7 days, a 4.4% decline over 30 days, a 10.4% decline year to date, a 7.6% decline over the past year, and a 23.4% decline over three years.\nRecent coverage has focused on how Privia Health Group fits into broader trends in...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4196":"保健护理服务","BK4581":"高盛持仓","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","PRVA":"Privia Health Group, Inc."},"translate_title":"在股价长期疲软之后，是时候重新评估Privia Health Group(PRVA)了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"PRVA":1.5},"content_text":"For investors considering whether Privia Health Group at around US$21.03 is attractively priced or potentially a value trap, this article walks through key clues in the current market pricing. The stock has seen mixed sentiment, with returns of a 4.8% decline over 7 days, a 4.4% decline over 30 days, a 10.4% decline year to date, a 7.6% decline over the past year, and a 23.4% decline over three years. Recent coverage has focused on how Privia Health Group fits into broader trends in healthcare services and how investors are reassessing companies that blend technology with physician networks. This context helps explain why the share price has been under pressure while expectations around long term business models in healthcare are being re examined. On Simply Wall St's valuation checks, Privia Health Group currently scores 3 out of 6. Next, you will see how different valuation methods line up on the stock and, at the very end, a way to put those numbers into a fuller story.  Privia Health Group delivered -7.6% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementApproach 1: Privia Health Group Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow model takes the cash that a business is expected to generate in the future, then discounts those amounts back to today to estimate what the company might be worth right now. For Privia Health Group, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month Free Cash Flow is about $163.4 million. Analysts have provided detailed forecasts out to 2030, including a projected Free Cash Flow of $204 million in 2030, with later years extrapolated by Simply Wall St beyond the analyst window. Aggregating and discounting these projected cash flows gives an estimated intrinsic value of about $42.82 per share. Compared to a recent share price around $21.03, the DCF output suggests the stock trades at a 50.9% discount to this estimate, which indicates undervaluation on this specific cash flow view. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Privia Health Group is undervalued by 50.9%. Track this in your watchlist or portfolio, or discover 58 more high quality undervalued stocks. PRVA Discounted Cash Flow as at Mar 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Privia Health Group. Approach 2: Privia Health Group Price vs Earnings For profitable companies, the P/E ratio is a useful shorthand for how much investors are currently paying for each dollar of earnings, which helps you compare pricing across different stocks quickly. What counts as a “normal” or “fair” P/E depends on how the market views a company’s growth prospects and risk profile. Higher expected growth or lower perceived risk can support a higher P/E, while slower growth or higher risk usually calls for a lower P/E. Privia Health Group currently trades on a P/E of 113.49x. That is well above the Healthcare industry average P/E of 21.46x and also above the peer group average of 28.58x. To go a step further, Simply Wall St calculates a proprietary “Fair Ratio” of 29.44x for Privia Health Group. This Fair Ratio estimates the P/E that might be reasonable given factors such as earnings growth, profit margins, industry, market cap and specific risks, so it can be more tailored than a simple comparison with peers or sector averages. With the current P/E of 113.49x sitting far above the Fair Ratio of 29.44x, the stock screens as expensive on this earnings based metric. Result: OVERVALUED NasdaqGS:PRVA P/E Ratio as at Mar 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies. Upgrade Your Decision Making: Choose your Privia Health Group Narrative Earlier it was mentioned that there is an even better way to understand valuation. Think of a Narrative as your own clear story for Privia Health Group that connects what you believe about its future revenue, earnings and margins to a forecast, a fair value, and finally a simple comparison of that fair value to the current share price. All of this happens within an easy tool on Simply Wall St's Community page that millions of investors use. Narratives update automatically when new earnings or news arrive. One investor might build a more optimistic Privia view closer to the US$35 analyst high target, while another might anchor nearer the US$21 low target, each using the same company data but drawing different conclusions about whether the current price lines up with their story. Do you think there's more to the story for Privia Health Group? Head over to our Community to see what others are saying! NasdaqGS:PRVA 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622045311","isCrawlerRequest":true}